Fundraising FoxIncite Health Life Sciences
Doylestown, US · Founded 2016 · Delaware corporation
Find your way into Incite Health Life Sciences
Sign up to see every warm intro you have to Incite Health Life Sciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Incite Health Life Sciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
JA
Julie A. BickExecutiveJulie A. Bick is a co-founder of Incite Health Life Sciences, a company focused on medical device and clinical assay development. She has led scientific projects in the medical device and clinical assay sectors.
EG
Edward GilesExecutive
JS
John SoenksenExecutive
RJ
Renold J. CapocasaleNamed on SEC filing
Board
DR
David RushBoard director
SS
Steven SciarrettaBoard director
SW
Skip WildayBoard director
FR
Frank RicottaBoard director
JM
JeanMarie MarkhamBoard director
DG
Daniel GambinoBoard director
Reported raises · per SEC filings
Form D private placements$1.7M disclosed across 3 rounds · 2017–2025
▶$330.7KraisedMay 2025 · 3 investors · Other Health CareRule 506(b)
▶$330.7KraisedMay 2025 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- David RushDirector
- Steven SciarrettaDirector
- Julie A. BickExecutive Officer, Director
- Skip WildayDirector
- Frank RicottaDirector
- Renold J. CapocasaleExecutive Officer, Director
- JeanMarie MarkhamDirector
- Daniel GambinoDirector
- Offering amount
- $2M
- Amount sold
- $330.7K
- Minimum investment
- $50K
- First sale
- May 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$585KraisedApr 2019 · 6 investors · Other Health CareRule 506(b)
▶$585KraisedApr 2019 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ward WildayDirector
- Eric HalbergDirector
- Daniel GambinoDirector
- Raymond DouglasDirector
- Julie BickExecutive Officer
- Edward GilesExecutive Officer
- Renold J. CapocasaleExecutive Officer, Director
- Denis J. ManginelliExecutive Officer
- Jonni S. MooreDirector
- John HealeyExecutive Officer, Director
- Martin SmithDirector
- Frank RicottaDirector
- Loretta JosephDirector
- Offering amount
- $1.2M
- Amount sold
- $585K
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$820KraisedJan 2017 · 8 investors · Other Health CareRule 506(b)
▶$820KraisedJan 2017 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Renold J. CapocasaleExecutive Officer, Director
- Edward GilesExecutive Officer
- John SoenksenExecutive Officer
- Julie BickExecutive Officer
- Offering amount
- $2M
- Amount sold
- $820K
- First sale
- Jan 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Incite Health Life Sciences raised?
- Incite Health Life Sciences has disclosed $1.7M raised across 3 rounds.
- Where is Incite Health Life Sciences headquartered?
- Incite Health Life Sciences is headquartered in Doylestown, US.